Literature DB >> 8630381

The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.

P Batard1, P Sansilvestri, C Scheinecker, W Knapp, N Debili, W Vainchenker, H J Bühring, M N Monier, E Kukk, J Partanen, M T Matikainen, R Alitalo, J Hatzfeld, K Alitalo.   

Abstract

Growth factor receptors in human hematopoietic progenitor cells have become the focus of intense interest, because they may provide tools for the monitoring, enrichment, and expansion of stem cells. We have shown earlier that the Tie receptor tyrosine kinase is expressed in erythroid and megakaryoblastic human leukemia cell lines, in the blood islands of the yolk sac, and in endothelial cells starting from day 8.0 of mouse development. Here, the expression of Tie was studied in human hematopoietic cells of various sources. Peripheral blood mononuclear cells were Tie-. However, a large fraction of CD34+ cells from umbilical cord blood (UCB) and bone marrow (BM) expressed tie protein and mRNA. On average, 64% of the fluorescence-activated cell sorting-gated UCB CD34+ cells including CD38- cells and a fraction of cells expressing low levels of c-Kit were Tie+. Also, 30% to 60% of BM CD34+ cells were Tie+, including most of the BM CD34+CD38-, CD34+Thy-1+, and CD34+HLA-DR- cells. Under culture conditions allowing myeloid, erythroid, and/or megakaryocytic differentiation, purified UCB CD34+ cells lost Tie mRNA and protein expression concomitantly with that of CD34; however, a significant fraction of cells expressed Tie during megakaryocytic differentiation. These data suggest that, in humans, the Tie receptor and presumably its ligand may function at an early stage of hematopoietic cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630381

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Regulation of lymphatic-blood vessel separation by endothelial Rac1.

Authors:  Gabriela D'Amico; Dylan T Jones; Emma Nye; Karen Sapienza; Antoine R Ramjuan; Louise E Reynolds; Stephen D Robinson; Vassiliki Kostourou; Dolores Martinez; Deborah Aubyn; Richard Grose; Gareth J Thomas; Bradley Spencer-Dene; Daniel Zicha; Derek Davies; Victor Tybulewicz; Kairbaan M Hodivala-Dilke
Journal:  Development       Date:  2009-12       Impact factor: 6.868

2.  Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection.

Authors:  Jennifer L Head Wheeler; Kyle C Martin; B Paige Lawrence
Journal:  J Immunol       Date:  2012-12-10       Impact factor: 5.422

Review 3.  Tie-1: A potential target for anti-angiogenesis therapy.

Authors:  Ping Yang; Na Chen; Jing-Hui Jia; Xue-Jiao Gao; Shi-Han Li; Jing Cai; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

4.  Signaling and functions of angiopoietin-1 in vascular protection.

Authors:  Nicholas P J Brindle; Pipsa Saharinen; Kari Alitalo
Journal:  Circ Res       Date:  2006-04-28       Impact factor: 17.367

5.  Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.

Authors:  Melissa K Brunckhorst; Yin Xu; Rong Lu; Qin Yu
Journal:  Am J Pathol       Date:  2014-08       Impact factor: 4.307

Review 6.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

7.  Patho-Mechanisms for Hemorrhage/Sepsis-Induced Indirect Acute Respiratory Distress Syndrome: A Role for Lung TIE1 and Its Regulation by Neutrophils.

Authors:  Jiali Zhu; Jinbao Li; Chun-Shiang Chung; Joanne L Lomas-Neira; Alfred Ayala
Journal:  Shock       Date:  2022-04-01       Impact factor: 3.454

Review 8.  Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1.

Authors:  Shigetomo Fukuhara; Keisuke Sako; Kazuomi Noda; Kaori Nagao; Koichi Miura; Naoki Mochizuki
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

9.  Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis.

Authors:  Mira C Puri; Alan Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

10.  Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Go Yamamoto; Soren Lehmann; Ross L Levine; Yana Pikman; Yasuhito Nannya; Masashi Sanada; Carl W Miller; D Gary Gilliland; H Phillip Koeffler
Journal:  Exp Hematol       Date:  2008-08-23       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.